Literature DB >> 21872374

Bleeding and thrombotic complications of kidney disease.

Sue Pavord1, Bethan Myers.   

Abstract

With the rising prevalence of kidney disease, clinicians are increasingly faced with concerns about potential thrombotic and bleeding complications. Thrombotic risk, both arterial and venous, predominates with all severities of kidney disease but bleeding manifestations become an additional concern particularly with uraemia. This article reviews these contrasting problems and discusses strategies for prevention and management in the context of renal impairment, renal replacement therapy and renal transplantation. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21872374     DOI: 10.1016/j.blre.2011.07.001

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  33 in total

1.  Evaluation of Heparin Anticoagulation Protocols in Post-Renal Transplant Recipients (EHAP-PoRT Study).

Authors:  Joan Chung Yan Ng; Marianna Leung; David Landsberg
Journal:  Can J Hosp Pharm       Date:  2016-04-29

Review 2.  Use of Non-Vitamin K Antagonist Oral Anticoagulants in Special Patient Populations with Nonvalvular Atrial Fibrillation: A Review of the Literature and Application to Clinical Practice.

Authors:  Julie Kalabalik; Gail B Rattinger; Jesse Sullivan; Malgorzata Slugocki; Antonia Carbone; Anastasia Rivkin
Journal:  Drugs       Date:  2015-06       Impact factor: 9.546

Review 3.  Role of direct oral anticoagulants in patients with kidney disease.

Authors:  Vimal K Derebail; Michelle N Rheault; Bryce A Kerlin
Journal:  Kidney Int       Date:  2019-12-24       Impact factor: 10.612

Review 4.  New oral anticoagulants: a review of the literature with particular emphasis on patients with impaired renal function.

Authors:  Birgitte Klindt Poulsen; Erik Lerkevang Grove; Steen Elkjaer Husted
Journal:  Drugs       Date:  2012-09-10       Impact factor: 9.546

5.  Targeted and non-targeted liver biopsies carry the same risk of complication.

Authors:  Anna Maheux; Yvonne Purcell; Sana Harguem; Valérie Vilgrain; Maxime Ronot
Journal:  Eur Radiol       Date:  2019-05-10       Impact factor: 5.315

Review 6.  Coagulopathy in liver disease: Lack of an assessment tool.

Authors:  Annabel Blasi
Journal:  World J Gastroenterol       Date:  2015-09-21       Impact factor: 5.742

Review 7.  Platelets in liver and renal disease.

Authors:  Michele P Lambert
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

Review 8.  Safety of new oral anticoagulant drugs: a perspective.

Authors:  Juan Antonio Vílchez; Pilar Gallego; Gregory Y H Lip
Journal:  Ther Adv Drug Saf       Date:  2014-02

9.  Anticoagulant strategies for the patient with chronic kidney disease.

Authors:  Jonathan P Law; Luke Pickup; Jonathan N Townend; Charles J Ferro
Journal:  Clin Med (Lond)       Date:  2020-03       Impact factor: 2.659

Review 10.  Prophylaxis of Pulmonary Embolism in Kidney Transplant Recipients.

Authors:  Federico Cicora; Jorgelina Petroni; Javier Roberti
Journal:  Curr Urol Rep       Date:  2018-02-23       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.